The Pharmaceutical Packaging Market size was USD 137.80 billion in 2023 and is expected to Reach USD 284.82 billion by 2031 and grow at a CAGR of 9.5 % over the forecast period of 2024-2031.
One of the main factors driving the pharmaceutical packaging market's growth is the enormous expansion of the pharmaceutical industry. Scientific and technological advancements have caused the pharmaceutical industry to grow quickly in recent years, and it is expected that this trend will continue over the projection period, particularly in developing countries like China, India, and Brazil. The largest pharmaceutical market worldwide was in the US.
Get PDF Sample Copy of Pharmaceutical Packaging Market - Request Sample Report
The advancement of medicine and bioscience is what primarily drives the pharmaceutical industry. The pharmaceutical industry is undergoing a significant transformation, and over the past few years, the emphasis on developing biopharmaceutical drugs has significantly increased. Few biotechnology-based drug therapies are introduced as lyophilized or dry powder dosage forms because they are unstable in liquid form. Lyophilized medications require Sustainable Pharmaceutical Packaging for their best performance, creating new business opportunities for packaging suppliers.
Pharmaceutical medications are primarily sold as tablets, capsules, liquids, and powders. They are packaged in a variety of packaging formats, such as rigid bottles, standup pouches, flat pouches, sachets, and Blister Packaging. The incorporation of dispensing mechanisms, administration aids, sustainable materials, tamper-evident characteristics, and anti-counterfeiting measures into packaging is a growing area of focus for packaging companies.
To increase the use of green packaging, businesses are primarily focusing on the use of post-consumer recycled (PCR) material and developing packaging from compostable material.
KEY DRIVERS:
The pharmaceutical packaging industry is influenced by technological advancements
Serialization, track-and-trace methods, and active & intelligent packaging techniques are all examples of printing technology. These technological advancements help to increase safety, efficiency, supply chain visibility, and patient engagement, which helps to advance the market.
Pharmaceutical products are in higher demand as a result of the aging population, the growing number of chronic diseases, and the expanding global population.
RESTRAIN:
Limited access to proper healthcare in low-income economies
Due to financial limitations, access to quality healthcare is frequently restricted in low-income or underserved populations. This may lead to a decreased ability to afford pharmaceutical products, affecting both the demand for packaging solutions and the overall demand for medications.
The pharmaceutical industry faces significant risks related to counterfeit drugs and tampering. This is a restraining factor for the pharmaceutical packaging market.
OPPORTUNITY:
Growing Demand for Patient-Centric Packaging
Patient-centric packaging strategies that improve medication adherence, usability, and patient safety are receiving more attention. There are opportunities for packaging designs that include elements like user-friendly dosing mechanisms, clear instructions, and enhanced accessibility for patients with special needs or disabilities.
Large growth potential exists in the pharmaceutical packaging market in emerging markets, particularly in Asia, Latin America, and Africa.
CHALLENGES:
Counterfeit drugs and tampering pose serious challenges to the pharmaceutical packaging market
Patient safety and brand reputation are seriously threatened by counterfeit drugs and tampering. The pharmaceutical packaging industry is constantly challenged with creating and putting into practice efficient anti-counterfeiting measures, such as track-and-trace technologies, holograms, and authentication systems, to stop illegal activities and protect the supply chain.
Aesthetic product operations have been suspended, and new clinical trials in Russia have been put on hold, by the American biopharma company AbbVie. Many companies, including Pfizer, Bayer, Sanofi, and others, have postponed new investments or construction in the nation.
However, in accordance with international humanitarian law, pharmaceutical companies like Abbott Laboratories and Johnson and Johnson have maintained operations in Russia and provided access to medications and medical supplies.
US, UK, Europe and Canada have disconnected seven Russian banks from the SWIFT global payment system, refusing to pay for medicines and medical supplies. This had an effect on the export of medical equipment from the EU to Russia.
The ongoing war has also hampered trade with India, one of Russia's major suppliers of generic medications. Pharmaceutical companies in a number of Indian states claimed they hadn't been paid for medicines exported to Russia.
Shipments to the Commonwealth of Independent States, Russia, and Ukraine are backed up at Indian ports. Production cycles have been hampered by payment delays, which have left manufacturers with little cash to cover daily expenses.
The rising cost of aluminum foil, which is frequently used in drug packaging, has added pressure to the already constrained supply. The export of foil is frequently notable.
Because of the diversity of the biopharmaceutical market, it is difficult to make generalizations about how a recession might affect it. Therefore, it's crucial to distinguish between the possible effects of the recession on various industry players. For instance, the generics industry would probably be affected differently than the research-based drug industry.
The compound annual growth rate of R&D spending in the pharmaceutical industry will abruptly decline during a recession. The industry will also invest significantly less in R&D.
By Raw Material
Plastics
Polymers
Aluminium Foil
Others
By Product Type
Primary
Secondary
By End Use
Pharma Manufacturing
Retail Pharmacy
Institutional Pharmacy
Contract Packaging
Get Customized Report as per Your Business Requiremrnt - Enquiry Now
In 2023, the North American region dominated the pharmaceutical packaging market with a total market revenue share of 37%. The presence of many pharmaceutical packaging manufacturers in the region has given growth in the region.
During the forecast period, Asia Pacific is anticipated to experience the fastest CAGR of more than 10 %. Over the forecast period, it is anticipated that rising disposable income levels and rising health awareness among consumers in the Asia Pacific, particularly in developing nations like China and India, will support the growth of the pharmaceutical industry and increase demand for its packaging. Due to expanding government initiatives, rising contract manufacturing activities, and a rapidly aging population, China is dominating the Asia Pacific regional market.
Due to increased R&D efforts and the introduction of new medications aimed at enhancing patient health and quality of life, Europe is predicted to experience significant growth.
REGIONAL COVERAGE:
North America
USA
Canada
Mexico
Europe
Germany
UK
France
Italy
Spain
The Netherlands
Rest of Europe
Asia-Pacific
Japan
South Korea
China
India
Australia
Rest of Asia-Pacific
The Middle East & Africa
Israel
UAE
South Africa
Rest of the Middle East & Africa
Latin America
Brazil
Argentina
Rest of Latin American
Some major key players in the Pharmaceutical packaging market are West Pharmaceutical Services Inc, Gerresheimer AG, International Paper, Vetter Pharma International, Schott AG, Drug Plastics Group, CCL Industries Inc, SGD Pharma, Becton, Dickinson, and Company, WestRock Company, and other players.
SGD Pharma, A joint venture between glass pharmaceutical packaging company SGD Pharma and materials science pioneer Corning has announced to establish a glass tubing facility in India.
Bormioli Pharma, A number of partnerships between companies have been announced by Bormioli Pharma with the goal of enhancing the functionality and sustainability of glass used in pharmaceutical applications.
| Report Attributes | Details |
| Market Size in 2023 | US$ 137.80 Bn |
| Market Size by 2031 | US$ 284.82 Bn |
| CAGR | CAGR of 9.5% From 2024 to 2031 |
| Base Year | 2023 |
| Forecast Period | 2024-2031 |
| Historical Data | 2020-2022 |
| Report Scope & Coverage | Market Size, Segments Analysis, Competitive Landscape, Regional Analysis, DROC & SWOT Analysis, Forecast Outlook |
| Key Segments | • by Raw Material (Plastics, Polymers, Paper & Paperboard, Aluminium Foil, Others) • by Product Type (Primary, Secondary) • by End Use (Pharma Manufacturing, Retail Pharmacy, Institutional Pharmacy, Contract Packaging) |
| Regional Analysis/Coverage | North America (USA, Canada, Mexico), Europe (Germany, UK, France, Italy, Spain, Netherlands, Rest of Europe), Asia-Pacific (Japan, South Korea, China, India, Australia, Rest of Asia-Pacific), The Middle East & Africa (Israel, UAE, South Africa, Rest of Middle East & Africa), Latin America (Brazil, Argentina, Rest of Latin America) |
| Company Profiles | West Pharmaceutical Services Inc, Gerresheimer AG, International Paper, Vetter Pharma International, Schott AG, Drug Plastics Group, CCL Industries Inc, SGD Pharma, Becton, Dickinson, and Company, WestRock Company |
| Key Drivers | • The pharmaceutical packaging industry is influenced by technological advancements • Pharmaceutical products are in higher demand as a result of the aging population, the growing number of chronic diseases, and the expanding global population. |
| Market Opportunities | • Growing Demand for Patient-Centric Packaging • Large growth potential exists in the pharmaceutical packaging market in emerging markets, particularly in Asia, Latin America, and Africa. |
Ans: Pharmaceutical Packaging Market is expected to grow at a CAGR of 9.5 % over the forecast period of 2023-2030.
Ans: The Pharmaceutical Packaging Market size was USD 137.80 Bn in 2023 and is expected to Reach USD 284.82 Bn by 2031.
Ans: The pharmaceutical packaging industry is influenced by technological advancements
Ans: Some major key players in the Pharmaceutical packaging market are West Pharmaceutical Services Inc, Gerresheimer AG, International Paper, Vetter Pharma International, Schott AG, Drug Plastics Group, CCL Industries Inc, SGD Pharma, Becton, Dickinson, and Company, WestRock Company.
Ans: In 2023, the North American region dominated the pharmaceutical packaging market with a total market revenue share of 37%.
Table of Contents
1. Introduction
1.1 Market Definition
1.2 Scope
1.3 Research Assumptions
2. Research Methodology
3. Market Dynamics
3.1 Drivers
3.2 Restraints
3.3 Opportunities
3.4 Challenges
4. Impact Analysis
4.1 Impact of the Russia-Ukraine War
4.2 Impact of Ongoing Recession
4.2.1 Introduction
4.2.2 Impact on major economies
4.2.2.1 US
4.2.2.2 Canada
4.2.2.3 Germany
4.2.2.4 France
4.2.2.5 United Kingdom
4.2.2.6 China
4.2.2.7 Japan
4.2.2.8 South Korea
4.2.2.9 Rest of the World
4.3 Supply Demand Gap Analysis
5. Value Chain Analysis
6. Porter’s 5 forces model
7. PEST Analysis
8. Pharmaceutical Packaging MarketSegmentation, By Raw Material
8.1 Plastics
8.2 Polymers
8.3 Paper & Paperboard
8.4 Aluminium Foil
8.5 Others
9. Pharmaceutical Packaging MarketSegmentation, By Product Type
9.1 Primary
9.2 Secondary
10. Pharmaceutical Packaging Market Segmentation, By End Use
10.1 Pharma Manufacturing
10.2 Retail Pharmacy
10.3 Institutional Pharmacy
10.4 Contract Packaging
11. Regional Analysis
11.1 Introduction
11.2 North America
11.2.1 North America Pharmaceutical Packaging Market by Country
11.2.2North America Pharmaceutical Packaging Market By Raw Material
11.2.3 North America Pharmaceutical Packaging Market By Product Type
11.2.4 North America Pharmaceutical Packaging Market By End Use
11.2.6 USA
11.2.6.1 USA Pharmaceutical Packaging Market By Raw Material
11.2.6.2 USA Pharmaceutical Packaging Market By Product Type
11.2.6.3 USA Pharmaceutical Packaging Market by End Use
11.2.7 Canada
11.2.7.1 Canada Pharmaceutical Packaging Market By Raw Material
11.2.7.2 Canada Pharmaceutical Packaging Market By Product Type
11.2.7.3 Canada Pharmaceutical Packaging Market By End Use
11.2.8 Mexico
11.2.8.1 Mexico Pharmaceutical Packaging Market By Raw Material
11.2.8.2 Mexico Pharmaceutical Packaging Market By Product Type
11.2.8.3 Mexico Pharmaceutical Packaging Market By End Use
11.3 Europe
11.3.1 Europe Pharmaceutical Packaging Market by Country
11.3.2 Europe Pharmaceutical Packaging Market By Raw Material
11.3.3 Europe Pharmaceutical Packaging Market By Product Type
11.3.4 Europe Pharmaceutical Packaging Market By End Use
11.3.6 Germany
11.3.6.1 Germany Pharmaceutical Packaging Market By Raw Material
11.3.6.2 Germany Pharmaceutical Packaging Market By Product Type
11.3.6.3 Germany Pharmaceutical Packaging Market By End Use
11.3.7 UK
11.3.7.1 UK Pharmaceutical Packaging Market By Raw Material
11.3.7.2 UK Pharmaceutical Packaging Market By Product Type
11.3.7.3 UK Pharmaceutical Packaging Market By End Use
11.3.8 France
11.3.8.1 France Pharmaceutical Packaging Market By Raw Material
11.3.8.2 France Pharmaceutical Packaging Market By Product Type
11.3.8.3 France Pharmaceutical Packaging Market By End Use
11.3.9 Italy
11.3.9.1 Italy Pharmaceutical Packaging Market By Raw Material
11.3.9.2 Italy Pharmaceutical Packaging Market By Product Type
11.3.9.3 Italy Pharmaceutical Packaging Market By End Use
11.3.10 Spain
11.3.10.1 Spain Pharmaceutical Packaging Market By Raw Material
11.3.10.2 Spain Pharmaceutical Packaging Market By Product Type
11.3.10.3 Spain Pharmaceutical Packaging Market By End Use
11.3.11 The Netherlands
11.3.11.1 Netherlands Pharmaceutical Packaging Market By Raw Material
11.3.11.2 Netherlands Pharmaceutical Packaging Market By Product Type
11.3.11.3 Netherlands Pharmaceutical Packaging Market By End Use
11.3.11 Rest of Europe
11.3.11.1 Rest of Europe Pharmaceutical Packaging Market By Raw Material
11.3.11.2 Rest of Europe Pharmaceutical Packaging Market By Product Type
11.3.11.3 Rest of Europe Pharmaceutical Packaging Market By End Use
11.4 Asia-Pacific
11.4.1 Asia Pacific Pharmaceutical Packaging Market by Country
11.4.2 Asia Pacific Pharmaceutical Packaging Market By Raw Material
11.4.3 Asia Pacific Pharmaceutical Packaging Market By Product Type
11.4.4Asia Pacific Pharmaceutical Packaging Market By End Use
11.4.6 Japan
11.4.6.1 Japan Pharmaceutical Packaging Market By Raw Material
11.4.6.2 Japan Pharmaceutical Packaging Market By Product Type
11.4.6.3 Japan Pharmaceutical Packaging Market By End Use
11.4.7 South Korea
11.4.7.1 South Korea Pharmaceutical Packaging Market By Raw Material
11.4.7.2 South Korea Pharmaceutical Packaging Market By Product Type
11.4.7.3 South Korea Pharmaceutical Packaging Market By End Use
11.4.8 China
11.4.8.1 China Pharmaceutical Packaging Market By Raw Material
11.4.8.2 China Pharmaceutical Packaging Market By Product Type
11.4.8.3 China Pharmaceutical Packaging Market By End Use
11.4.9 India
11.4.9.1 India Pharmaceutical Packaging Market By Raw Material
11.4.9.2 India Pharmaceutical Packaging Market By Product Type
11.4.9.3 India Pharmaceutical Packaging Market By End Use
11.4.10 Australia
11.4.10.1 Australia Pharmaceutical Packaging Market By Raw Material
11.4.10.2 Australia Pharmaceutical Packaging Market By Product Type
11.4.10.3 Australia Pharmaceutical Packaging Market By End Use
11.4.11 Rest of Asia-Pacific
11.4.11.1 APAC Pharmaceutical Packaging Market By Raw Material
11.4.11.2 APAC Pharmaceutical Packaging Market By Product Type
11.4.11.3 APAC Pharmaceutical Packaging Market By End Use
11.5 The Middle East & Africa
11.5.1 The Middle East & Africa Pharmaceutical Packaging Market by Country
11.5.2 The Middle East & Africa Pharmaceutical Packaging Market By Raw Material
11.5.3 The Middle East & Africa Pharmaceutical Packaging Market By Product Type
11.5.4The Middle East & Africa Pharmaceutical Packaging Market By End Use
11.5.6 Israel
11.5.6.1 Israel Pharmaceutical Packaging Market By Raw Material
11.5.6.2 Israel Pharmaceutical Packaging Market By Product Type
11.5.6.3 Israel Pharmaceutical Packaging Market By End Use
11.5.7 UAE
11.5.7.1 UAE Pharmaceutical Packaging Market By Raw Material
11.5.7.2 UAE Pharmaceutical Packaging Market By Product Type
11.5.7.3 UAE Pharmaceutical Packaging Market By End Use
11.5.8 South Africa
11.5.8.1 South Africa Pharmaceutical Packaging Market By Raw Material
11.5.8.2 South Africa Pharmaceutical Packaging Market By Product Type
11.5.8.3 South Africa Pharmaceutical Packaging Market By End Use
11.5.9 Rest of Middle East & Africa
11.5.9.1 Rest of Middle East & Asia Pharmaceutical Packaging Market By Raw Material
11.5.9.2 Rest of Middle East & Asia Pharmaceutical Packaging Market By Product Type
11.5.9.3 Rest of Middle East & Asia Pharmaceutical Packaging Market By End Use
11.6 Latin America
11.6.1 Latin America Pharmaceutical Packaging Market by Country
11.6.2 Latin America Pharmaceutical Packaging Market By Raw Material
11.6.3 Latin America Pharmaceutical Packaging Market By Product Type
11.6.4 Latin America Pharmaceutical Packaging Market By End Use
11.6.6 Brazil
11.6.6.1 Brazil Pharmaceutical Packaging Market By Raw Material
11.6.6.2 Brazil Africa Pharmaceutical Packaging Market By Product Type
11.6.6.3 Brazil Pharmaceutical Packaging Market By End Use
11.6.7 Argentina
11.6.7.1 Argentina Pharmaceutical Packaging Market By Raw Material
11.6.7.2 Argentina Pharmaceutical Packaging Market By Product Type
11.6.7.3 Argentina Pharmaceutical Packaging Market by By End Use
11.6.8 Rest of Latin America
11.6.8.1 Rest of Latin America Pharmaceutical Packaging Market By Raw Material
11.6.8.2 Rest of Latin America Pharmaceutical Packaging Market By Product Type
11.6.8.3 Rest of Latin America Pharmaceutical Packaging Market By End Use
12 Company Profile
12.1 West Pharmaceutical Services Inc
12.1.1 Market Overview
12.1.2 Financials
12.1.3 Product/Services/Offerings
12.1.4 SWOT Analysis
12.1.5 The SNS View
12.2 Gerresheimer AG
12.2.1 Market Overview
12.2.2 Financials
12.2.3 Product/Services/Offerings
12.2.4 SWOT Analysis
12.2.5 The SNS View
12.3 International Paper
12.3.1 Market Overview
12.3.2 Financials
12.3.3 Product/Services/Offerings
12.3.4 SWOT Analysis
12.3.5 The SNS View
12.4 Vetter Pharma International
12.4.1 Market Overview
12.4.2 Financials
12.4.3 Product/Services/Offerings
12.4.4 SWOT Analysis
12.4.5 The SNS View
12.5 Schott AG
12.5.1 Market Overview
12.5.2 Financials
12.5.3 Product/Services/Offerings
12.5.4 SWOT Analysis
12.5.5 The SNS View
12.6 Drug Plastics Group
12.6.1 Market Overview
12.6.2 Financials
12.6.3 Product/Services/Offerings
12.6.4 SWOT Analysis
12.6.5 The SNS View
12.7 CCL Industries Inc
12.7.1 Market Overview
12.7.2 Financials
12.7.3 Product/Services/Offerings
12.7.4 SWOT Analysis
12.7.5 The SNS View
12.8 SGD Pharma
12.8.1 Market Overview
12.8.2 Financials
12.8.3 Product/Services/Offerings
12.8.4 SWOT Analysis
12.8.5 The SNS View
12.9 Becton, Dickinson, and Company
12.9.1 Market Overview
12.9.2 Financials
12.9.3 Product/Services/Offerings
12.9.4 SWOT Analysis
12.9.5 The SNS View
12.10 WestRock Company
12.10.1 Market Overview
12.10.2 Financials
12.10.3 Product/Services/Offerings
12.10.4 SWOT Analysis
12.10.5 The SNS View
13. Competitive Landscape
13.1 Competitive Benchmarking
13.2 Market Share Analysis
13.3 Recent Developments
14. USE Cases and Best Practices
15. Conclusion
An accurate research report requires proper strategizing as well as implementation. There are multiple factors involved in the completion of good and accurate research report and selecting the best methodology to compete the research is the toughest part. Since the research reports we provide play a crucial role in any company’s decision-making process, therefore we at SNS Insider always believe that we should choose the best method which gives us results closer to reality. This allows us to reach at a stage wherein we can provide our clients best and accurate investment to output ratio.
Each report that we prepare takes a timeframe of 350-400 business hours for production. Starting from the selection of titles through a couple of in-depth brain storming session to the final QC process before uploading our titles on our website we dedicate around 350 working hours. The titles are selected based on their current market cap and the foreseen CAGR and growth.
The 5 steps process:
Step 1: Secondary Research:
Secondary Research or Desk Research is as the name suggests is a research process wherein, we collect data through the readily available information. In this process we use various paid and unpaid databases which our team has access to and gather data through the same. This includes examining of listed companies’ annual reports, Journals, SEC filling etc. Apart from this our team has access to various associations across the globe across different industries. Lastly, we have exchange relationships with various university as well as individual libraries.
Step 2: Primary Research
When we talk about primary research, it is a type of study in which the researchers collect relevant data samples directly, rather than relying on previously collected data. This type of research is focused on gaining content specific facts that can be sued to solve specific problems. Since the collected data is fresh and first hand therefore it makes the study more accurate and genuine.
We at SNS Insider have divided Primary Research into 2 parts.
Part 1 wherein we interview the KOLs of major players as well as the upcoming ones across various geographic regions. This allows us to have their view over the market scenario and acts as an important tool to come closer to the accurate market numbers. As many as 45 paid and unpaid primary interviews are taken from both the demand and supply side of the industry to make sure we land at an accurate judgement and analysis of the market.
This step involves the triangulation of data wherein our team analyses the interview transcripts, online survey responses and observation of on filed participants. The below mentioned chart should give a better understanding of the part 1 of the primary interview.
Part 2: In this part of primary research the data collected via secondary research and the part 1 of the primary research is validated with the interviews from individual consultants and subject matter experts.
Consultants are those set of people who have at least 12 years of experience and expertise within the industry whereas Subject Matter Experts are those with at least 15 years of experience behind their back within the same space. The data with the help of two main processes i.e., FGDs (Focused Group Discussions) and IDs (Individual Discussions). This gives us a 3rd party nonbiased primary view of the market scenario making it a more dependable one while collation of the data pointers.
Step 3: Data Bank Validation
Once all the information is collected via primary and secondary sources, we run that information for data validation. At our intelligence centre our research heads track a lot of information related to the market which includes the quarterly reports, the daily stock prices, and other relevant information. Our data bank server gets updated every fortnight and that is how the information which we collected using our primary and secondary information is revalidated in real time.
Step 4: QA/QC Process
After all the data collection and validation our team does a final level of quality check and quality assurance to get rid of any unwanted or undesired mistakes. This might include but not limited to getting rid of the any typos, duplication of numbers or missing of any important information. The people involved in this process include technical content writers, research heads and graphics people. Once this process is completed the title gets uploader on our platform for our clients to read it.
Step 5: Final QC/QA Process:
This is the last process and comes when the client has ordered the study. In this process a final QA/QC is done before the study is emailed to the client. Since we believe in giving our clients a good experience of our research studies, therefore, to make sure that we do not lack at our end in any way humanly possible we do a final round of quality check and then dispatch the study to the client.
The Aluminium Caps & Closures Market size was USD 7.06 billion in 2023 and is expected to Reach USD 9.59 Billion by 2031 and grow at a CAGR of 3.9 % over the forecast period of 2024-2031.
The Cosmetic Bottle Packaging Market Size was valued at USD 30.20 billion in 2023 and is expected to reach USD 41.81 billion by 2031 and grow at a CAGR of 4.15 % over the forecast period 2024-2031.
The Jerry Cans Market size was USD 2.83 billion in 2022 and is expected to Reach USD 3.99 billion by 2030 and grow at a CAGR of 4.4 % over the forecast period of 2023-2030.
The Produce Packaging Market size was USD 32.85 billion in 2022 and is expected to Reach USD 48.17 billion by 2030 and grow at a CAGR of 4.9% over the forecast period of 2023-2030.
The Food Packaging Films Market size was USD 54.65 billion in 2023 and is expected to Reach USD 91.13 billion by 2031 and grow at a CAGR of 6.6 % over the forecast period of 2024-2031.
Disposable Cups Market size was USD 13.60 billion in 2022 and is expected to Reach USD 23.37 billion by 2030 and grow at a CAGR of 7 % over the forecast period of 2023-2030.
Hi! Click one of our member below to chat on Phone
© 2024 All Rights Reserved by SNS Insider Pvt Ltd
